Iodine-123 β-methyl-P-iodophenyl-pentadecanoic Acid (¹²³I-BMIPP) Myocardial Scintigraphy for Breast Cancer Patients and Possible Early Signs of Cancer-Therapeutics-Related Cardiac Dysfunction (CTRCD)

(1) Background: The mortality of breast cancer has decreased due to the advancement of cancer therapies. However, more patients are suffering from cancer-therapeutics-related cardiac dysfunction (CTRCD). Diagnostic and treatment guidelines for CTRCD have not been fully established yet. Ultrasound ca...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yuko Harada, Kyosuke Shimada, Satoshi John Harada, Tomomi Sato, Yukino Kubota, Miyoko Yamashita
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2022-10-01
Col·lecció:	Journal of Imaging
Matèries:	breast cancer echocardiography <sup>123</sup>I-BMIPP myocardial scintigraphy chemotherapy-related cardiac dysfunction (CTRCD)
Accés en línia:	https://www.mdpi.com/2313-433X/8/11/296
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!